Allurion Announces Publication Of New Data Demonstrating Weight Loss In Adolescents Suffering From Obesity; In A Study Of 91 Adolescents, Average Weight Loss Was 13.1% At 4-Months With No Serious Adverse Events
Portfolio Pulse from Benzinga Newsdesk
Allurion Technologies, Inc. (NYSE:ALUR) announced new data from a study showing significant weight loss in adolescents using the Allurion Program. The study involved 91 adolescents and reported an average weight loss of 13.1% over four months with no serious adverse events.
September 05, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Allurion Technologies reported positive results from a study on their weight loss program for adolescents, showing significant weight loss and no serious adverse events. This could enhance the company's reputation and potentially boost stock prices.
The study results demonstrate the effectiveness and safety of Allurion's product, which could lead to increased adoption and sales. Positive clinical data often boosts investor confidence, potentially leading to a short-term increase in stock prices.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100